|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the * University of Calgary Sport Medicine Centre, Faculty of Kinesiology, Calgary, Alberta, Canada
Address correspondence to J. Preston Wiley, MD, University of Calgary Sport Medicine Centre, 2500 University Drive NW, Calgary, AB, Canada T2N 1N4 (e-mail: wiley{at}ucalgary.ca).
Background: Extracorporeal shock wave therapy is a relatively new therapy used in the treatment of chronic tendon-related pain. Few randomized controlled trials have been performed on it, and no studies have examined the effectiveness of extracorporeal shock wave therapy as a frontline therapy for tendon-related pain.
Hypothesis: Subjects treated with active extracorporeal shock wave therapy will have higher rates of treatment success than subjects treated with sham extracorporeal shock wave therapy.
Design: Double-blind randomized controlled trial.
Methods: Sixty subjects who had previously untreated lateral epicondylitis for less than 1 year and more than 3 weeks were included in this study. Subjects were randomly allocated to receive 1 session per week for 3 weeks of either sham or active extra-corporeal shock wave therapy. Subjects in the active therapy group received 2000 pulses (energy flux density, 0.030.17 mJ/mm2). All subjects were provided with a forearm-stretching program. After 8 weeks of therapy, subjects were classified as either treatment successes or treatment failures according to fulfillment of all 3 criteria: (1) at least a 50% reduction in the overall pain visual analog scale score, (2) a maximum allowable overall pain visual analog scale score of 4.0 cm, and (3) no use of pain medication for elbow pain for 2 weeks before the 8 week follow-up. Visual analog scale scores were also collected for pain at rest, during sleep, during activity, at its worst, and at its least, as well as for quality of life (using the EuroQoL questionnaire) and grip strength.
Results: Success rates in the sham and active therapy groups were 31% and 39%, respectively. No significant difference was detected between groups (
21= 0.3880, P = .533). Mean change in quality of life over 8 weeks was an increase of 1.3 and 3.3 for sham and active therapy groups, respectively, and mean change in grip strength over 8 weeks was an increase of 7.4 kg and 6.8 kg for sham and active therapy groups, respectively.
Conclusions: Despite improvement in pain scores and pain-free maximum grip strength within groups, there does not appear to be a meaningful difference between treating lateral epicondylitis with extracorporeal shock wave therapy combined with forearm-stretching program and treating with forearm-stretching program alone, with respect to resolving pain within an 8-week period of commencing treatment.
Key Words: lateral epicondylitis randomized controlled trial extracorporeal shock wave therapy (ESWT)
This article has been cited by other articles:
![]() |
M. Reza Nourbakhsh and F. J Fearon An alternative approach to treating lateral epicondylitis. A randomized, placebo-controlled, double-blinded study Clinical Rehabilitation, July 1, 2008; 22(7): 601 - 609. [Abstract] [PDF] |
||||
![]() |
J. D. Rompe and N. Maffulli Repetitive shock wave therapy for lateral elbow tendinopathy (tennis elbow): a systematic and qualitative analysis Br. Med. Bull., September 1, 2007; 83(1): 355 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cowan, S. Lozano-Calderon, and D. Ring Quality of Prospective Controlled Randomized Trials. Analysis of Trials of Treatment for Lateral Epicondylitis as an Example J. Bone Joint Surg. Am., August 1, 2007; 89(8): 1693 - 1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Pettrone and B. R. McCall Extracorporeal Shock Wave Therapy without Local Anesthesia for Chronic Lateral Epicondylitis J. Bone Joint Surg. Am., June 1, 2005; 87(6): 1297 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
Evidence based journal watch Br. J. Sports Med., May 1, 2005; 39(5): 309 - 310. [Full Text] [PDF] |
||||
![]() |
J. D. Rompe, B. Chung, and P. Wiley Letters to the Editor * Authors' Response Am. J. Sports Med., March 1, 2005; 33(3): 461 - 463. [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, November 27, 2004; 329(7477): 1296 - 1296. [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |